Effect of comorbidity on short-term outcomes and cost of care after head and neck cancer surgery in the elderly

Head and Neck

Volumn 37, Issue 5, 2015, Pages 685-693

  Genther, Dane J ^a   Gourin, Christine G ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

comorbidity; elderly; head and neck neoplasms; Nationwide Inpatient Sample; surgery

Indexed keywords

ABLATION THERAPY; ACUTE KIDNEY FAILURE; AGED; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURGERY; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC LUNG DISEASE; COMORBIDITY; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; DYSPHAGIA; FAILURE TO THRIVE; FEMALE; FRAIL ELDERLY; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LENGTH OF STAY; LIFE EXPECTANCY; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL PATIENT; WEIGHT REDUCTION; WOUND COMPLICATION; WOUND DEHISCENCE; CARCINOMA, SQUAMOUS CELL; CONFIDENCE INTERVAL; ECONOMICS; FACTUAL DATABASE; FOLLOW UP; GERIATRIC ASSESSMENT; HEAD AND NECK NEOPLASMS; HOSPITAL COST; MORTALITY; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HEAD AND NECK NEOPLASMS; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84928112430     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23651     Document Type: Conference Paper

References (31)

1. Jégu J, Binder-Foucard F, Borel C, Velten M,. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncol 2013; 49: 9-14.
2. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Polanczyk CA, Marcantonio E, Goldman L, et al. Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery. Ann Intern Med 2001; 134: 637-643.
4. Makary MA, Segev DL, Pronovost PJ, et al. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010; 210: 901-908.
5. Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-Dequéant B,. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 2001; 127: 1089-1092.
6. Derks W, de Leeuw JR, Hordijk GJ, Winnubst JA,. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol 2005; 262: 21-26.
7. Derks W, De Leeuw JR, Hordijk GJ, Winnubst JA,. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci 2003; 28: 399-405.
8. Grénman R, Chevalier D, Gregoire V, Myers E, Rogers S,. Treatment of head and neck cancer in the elderly: European Consensus (panel 6) at the EUFOS Congress in Vienna 2007. Eur Arch Otorhinolaryngol 2010; 267: 1619-1621.
9. Fairhall N, Langron C, Sherrington C, et al. Treating frailty-a practical guide. BMC Med 2011; 9: 83.
10. Ortholan C, Benezery K, Dassonville O, et al. A specific approach for elderly patients with head and neck cancer. Anticancer Drugs 2011; 22: 647-655.
11. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-M156.
12. Davis DH, Rockwood MR, Mitnitski AB, Rockwood K,. Impairments in mobility and balance in relation to frailty. Arch Gerontol Geriatr 2011; 53: 79-83.
13. Velanovich V, Antoine H, Swartz A, Peters D, Rubinfeld I,. Accumulating deficits model of frailty and postoperative mortality and morbidity: its application to a national database. J Surg Res 2013; 183: 104-110.
14. Sanabria A, Carvalho AL, Melo RL, et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008; 30: 170-177.
15. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP,. Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope 2007; 117: 835-840.
16. Kinsella K, Velkoff VA,. U.S. Census Bureau, Series P95/01-1. An Aging World: 2001. Washington, DC: U.S. Government Printing Office; 2001.
17. Overview of the Nationwide Inpatient Sample. Healthcare cost and utilization project website. Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed January 13, 2014.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
19. Liu JH, Zingmond DS, McGory ML, et al. Disparities in the utilization of high-volume hospitals for complex surgery. JAMA 2006; 296: 1973-1980.
20. Romano PS, Roos LL, Jollis JG,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993; 46: 1075-1079; discussion 1081-1090.
21. Neighbors CJ, Rogers ML, Shenassa ED, Sciamanna CN, Clark MA, Novak SP,. Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer. Med Care 2007; 45: 655-663.
22. Definitions of Comorbidities, Comorbidity software version 3.6 / 2011. Healthcare cost and utilization project website. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/Table2-FY2011-V3-6.pdf. Accessed January 13, 2014.
23. Cost-to-Charge Ratio Files. Healthcare cost and utilization project website. Available at: http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp. Accessed January 13, 2014.
24. Newhouse RP, Mills ME, Johantgen M, Pronovost PJ,. Is there a relationship between service integration and differentiation and patient outcomes? Int J Integr Care 2003; 3: e15.
25. Overview of BLS statistics on inflation and prices. U.S. Department of Labor. Bureau of Labor Statistics. Available at: http://www.bls.gov/bls/inflation.htm. Accessed January 13, 2014.
26. Jürschik P, Nunin C, Botigué T, Escobar MA, Lavedán A, Viladrosa M,. Prevalence of frailty and factors associated with frailty in the elderly population of Lleida, Spain: the FRALLE survey. Arch Gerontol Geriatr 2012; 55: 625-631.
27. Sanabria A, Carvalho AL, Vartanian JG, Magrin J, Ikeda MK, Kowalski LP,. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007; 14: 1449-1457.
28. Piccirillo JF,. Importance of comorbidity in head and neck cancer. Laryngoscope 2000; 110: 593-602.
29. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr,. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004; 291: 2441-2447.
30. Robinson TN, Wu DS, Stiegmann GV, Moss M,. Frailty predicts increased hospital and six-month healthcare cost following colorectal surgery in older adults. Am J Surg 2011; 202: 511-514.
31. Hirano M, Mori K,. Management of cancer in the elderly: therapeutic dilemmas. Otolaryngol Head Neck Surg 1998; 118: 110-114.